Preventing influenza in younger children

Area of Science:

• Pediatrics
• Immunology
• Public Health

Background:

• Influenza is a highly prevalent respiratory illness in infants and children, with annual attack rates ranging from 23% to 48%.
• While severe influenza cases are more common in children with chronic conditions, healthy children under five years old also experience significant morbidity, including hospitalizations and mortality.
• Social and economic burdens associated with childhood influenza are substantial, yet many European nations hesitate to include influenza vaccination in routine childhood immunization schedules due to concerns about vaccine efficacy in young children.

Purpose of the Study:

• To address the ongoing debate regarding the efficacy of influenza vaccination in young children.
• To evaluate the potential of novel influenza vaccines and administration routes, such as intradermal delivery, for improving immune response in pediatric populations.
• To inform recommendations on universal influenza vaccination strategies for infants and young children.

Main Methods:

• Epidemiological studies analyzing influenza attack rates and healthcare utilization in children.
• Evaluation of immune responses elicited by existing and novel influenza vaccine formulations.
• Assessment of intradermal versus intramuscular vaccine administration in pediatric cohorts.

Main Results:

• Influenza poses a significant health risk to children, including healthy individuals, leading to increased medical visits, prescriptions, hospitalizations, and deaths.
• Existing influenza vaccines may face challenges in eliciting a robust protective immune response in the youngest age groups.
• Emerging vaccine technologies, including multi-antigen vaccines and intradermal administration, show promise for enhancing pediatric influenza vaccine efficacy.

Conclusions:

• Influenza vaccination in early childhood warrants further investigation to establish optimal strategies.
• Newer vaccine formulations and administration methods may offer improved protection against influenza in infants and young children.
• Evidence is needed to support universal influenza vaccination recommendations for the first years of life, specifying the most effective vaccine types.